Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole 1% plus urea 40% versus fluconazole 1% alone for onychomycosis
IRCT138705301059N1Phase 3Completed
- Sponsor
- Institut Pasteur
- Start
- Jun 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluconazole in onychomycosis, sponsored by Institut Pasteur. Started Jun 2008; status: completed.
02
Drugs
fluconazole
03
Conditions
onychomycosis
Beyond the preview
Go deeper on IRCT138705301059N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138705301059N1.